Satellos Bioscience Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2026 · Filed Aug 13, 2026
Use the contents to explore the available documents and sections.
MSLE$7.19+13.2%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · OUTSTANDING SHARE DATA
OUTSTANDING SHARE DATA
As of the date of this MD&A, the Company had the following issued and outstanding securities:
| Security | Number |
|---|---|
| Common Shares | 21,216,439 |
| Pre-Funded Warrants | 3,072,564 |
| Stock Options | 2,723,237 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.